MYC and hepatocellular carcinoma: Among the genes frequently altered in HCC patients are TERT, TP53, MYC amplification, CTNNB1, and ARID1A, which occur in up to 60%, 48%, 33%, 30%, and 17% of cases, respectively [6–8].